Preston Klassen, President & Head of R & D: Regulus Therapeutics RGLS Sell · Filed 25/01/15

Trade details

Type: Insider sale
Amount: $39,620.7
Shares · price: 31,445 sh · $1.26 a share
Held after: 36,055 sh
Stock: Regulus Therapeutics RGLS
Person: Preston KlassenPresident & Head of R & D
Trade date: 25/01/13
Filed: 25/01/15
Days to filing: 2 days

Sold 46.6% of holdings

Share of holding sold: 46.6%

Regulus Therapeutics trades, last 26 weeks

What else happened in Regulus Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/14~25/02/12

Preston Klassen's recent trades

Preston KlassenPresident & Head of R & D
BuyRegulus Therapeutics
Buy
Regulus Therapeutics
RGLS
$95.9K
12,000 sh
$95.9K
Filed 25/06/04
Traded 25/06/03
Preston KlassenPresident & CEO
SellMetacrine
Sell
Metacrine
MTCR
$156K
380,605 sh
$156K
Filed 23/01/27
Traded 23/01/26

Preston Klassen, President — sold $39.6K of Regulus Therapeutics RGLS · 46.6% of holdings · 10b5-1 plan | Whalegun